Botanicals supplier Nektium has completed the first phase of securing patents in several markets for its mango leaf extract, Zynamite, which offers benefits for cognitive health and sports performance. The company will share more details about these, as well as the latest advancements for Zynamite, at stand H140 at Vitafoods Europe in Geneva.
Patents have been obtained for the ingredient in all major international markets. The patents refer to its ability to improve alertness, concentration, and memory. In some countries it also includes additional effects, such as its use for enhancing mood, reducing stress, and as a replacement for caffeine.
Further patent applications linked to sports performance are currently under review to complement the existing patents in the field of cognition, the company says.
Thomas Adler, Chief Business Officer at Nektium, said: “We are delighted to have several patents in place for Zynamite because it supports what we have achieved so far with this ingredient, and it confirms the innovative character of the product and of Nektium as an organisation.”
“Zynamite is a unique product which has been formulated to deliver both mental and physical energy, and this has been verified by human trials, publications and now, several patent families. Supplement and functional food manufacturers can be reassured by these patents, which support the claims about Zynamite’s beneficial effects on human health.”
